Literature DB >> 8020596

Apoptosis induced by adenosine in human leukemia HL-60 cells.

Y Tanaka1, K Yoshihara, M Tsuyuki, T Kamiya.   

Abstract

Among several nucleosides and nucleotides, which showed strong inhibition of growth of HL-60 cells, only adenosine (Ado) specifically induced typical apoptotic death of the cells, accompanying double-strand cleavage of DNA into nucleosomal size fragments, and subsequent apoptotic body formation. A marked enhancement of endogenous poly(ADP-ribosyl)ation activity in the cell was detected at a relatively early stage of cell death, whereas other nucleosides and nucleotides tested were ineffective on poly(ADP-ribosyl)ation activity, suggesting that the enzyme activation is closely related to apoptosis. The observed Ado effect was not mediated by Ado receptors, in contrast to the Ado-induced apoptotic death of thymocytes, judging from the facts that all of the receptor agonists tested did not substitute for Ado and that a receptor antagonist did not inhibit the effect of Ado. Ado transport into the cell seemed to be essential for the induction of apoptosis, since an inhibitor of Ado transport (dipyridamole) strongly suppressed apoptosis. Cytochalasin B blocked Ado-induced apoptotic body formation without affecting activation of endogenous poly(ADP-ribosyl)ation activity in the cell. Thus, the process of apoptosis in HL-60 cells induced by Ado seems to be separated into at least two steps, an initial step of DNA degradation and a following morphological change. While the adenine moiety of Ado was essential for its apoptosis-inducing activity, the sugar was replaceable, and various analogs with modified sugar were inducers of apoptosis, although they were less efficient than Ado.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020596     DOI: 10.1006/excr.1994.1196

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.

Authors:  M Hashemi; F Karami-Tehrani; S Ghavami; S Maddika; M Los
Journal:  Cell Prolif       Date:  2005-10       Impact factor: 6.831

2.  Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.

Authors:  Anke C Schiedel; Svenja K Lacher; Carsten Linnemann; Percy A Knolle; Christa E Müller
Journal:  Purinergic Signal       Date:  2013-01-29       Impact factor: 3.765

3.  Study of A(2A) adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A(2A) receptor-unrelated lymphotoxicity.

Authors:  S G Apasov; J F Chen; P T Smith; M A Schwarzschild; J S Fink; M V Sitkovsky
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.

Authors:  Y Kohno; Y Sei; M Koshiba; H O Kim; K A Jacobson
Journal:  Biochem Biophys Res Commun       Date:  1996-02-27       Impact factor: 3.575

5.  Mitochondrial and caspase pathways are involved in the induction of apoptosis by IB-MECA in ovarian cancer cell lines.

Authors:  Hamideh Abedi; Mahmoud Aghaei; Mojtaba Panjehpour; Sima Hajiahmadi
Journal:  Tumour Biol       Date:  2014-08-06

6.  Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3.

Authors:  Saeid Shirali; Mahmoud Aghaei; Mahdi Shabani; Mojtaba Fathi; Majid Sohrabi; Marzieh Moeinifard
Journal:  Tumour Biol       Date:  2013-01-24

7.  Adenosine induces intrinsic apoptosis via the PI3K/Akt/mTOR signaling pathway in human pharyngeal squamous carcinoma FaDu cells.

Authors:  Mi Suk Choi; Sung-Min Moon; Seul Ah Lee; Bo-Ram Park; Jae-Sung Kim; Do Kyung Kim; Yong Hwan Kim; Chun Sung Kim
Journal:  Oncol Lett       Date:  2018-02-20       Impact factor: 2.967

8.  Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells.

Authors:  Liwei Liu; Lars Herfindal; Jouni Jokela; Tania Keiko Shishido; Matti Wahlsten; Stein Ove Døskeland; Kaarina Sivonen
Journal:  Mar Drugs       Date:  2014-04-03       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.